SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-006483
Filing Date
2019-05-10
Accepted
2019-05-09 19:23:09
Documents
56
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20190331-10q.htm 10-Q 949768
2 EXHIBIT 10.1 ex-101x20190331.htm EX-10.1 100193
3 EXHIBIT 10.7 ex-107x20190331.htm EX-10.7 419847
4 EXHIBIT 31.1 ex-311x20190331.htm EX-31.1 12034
5 EXHIBIT 31.2 ex-312x20190331.htm EX-31.2 12058
6 EXHIBIT 32.1 ex-321x20190331.htm EX-32.1 11823
  Complete submission text file 0001628280-19-006483.txt   4960156

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgls-20190331.xml EX-101.INS 679415
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20190331.xsd EX-101.SCH 39963
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20190331_cal.xml EX-101.CAL 64941
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20190331_def.xml EX-101.DEF 198727
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20190331_lab.xml EX-101.LAB 546378
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20190331_pre.xml EX-101.PRE 312719
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 19812390
SIC: 2834 Pharmaceutical Preparations